Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.92% |
| 2 | Healthcare | 11.63% |
| 3 | Technology | 11.35% |
| 4 | Industrials | 10.55% |
| 5 | Consumer Staples | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRO
3001
DELISTED
Agria Corp
GRO
| $273K | ﹤0.01% |
276,000
+5,400
| +2% | +$5.7K |
|
|
GV
3002
DELISTED
Goldfield Corporation
GV
| $272K | ﹤0.01% |
160,000
+10,200
| +7% | +$14K |
|
3003
DLH Holdings
DLHC
$78.3M
| $269K | ﹤0.01% |
70,075
+4,700
| +7% | +$15.9K |
|
3004
Green Brick Partners
GRBK
$3.09B
| $269K | ﹤0.01% |
+35,435
| New | +$219K |
|
3005
NLI Holdings
NL
$289M
| $268K | ﹤0.01% |
118,399
+38,599
| +48% | +$91.5K |
|
|
VOXX
3006
DELISTED
VOXX International Corporation Class A
VOXX
| $268K | ﹤0.01% |
59,900
+45,200
| +307% | +$198K |
|
|
HCCI
3007
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $267K | ﹤0.01% |
26,900
+14,400
| +115% | +$126K |
|
|
CORV
3008
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $267K | ﹤0.01% |
65,313
+3,100
| +5% | +$16.6K |
|
3009
AMREP Corp
AXR
$124M
| $265K | ﹤0.01% |
60,280
+4,000
| +7% | +$16.1K |
|
3010
Mind CTI
MNDO
$21.6M
| $265K | ﹤0.01% |
131,200
-7,175
| -5% | -$16.5K |
|
|
TISA
3011
DELISTED
TOP Image Systems Ltd
TISA
| $264K | ﹤0.01% |
172,300
+43,600
| +34% | +$95.2K |
|
3012
First Bancorp
FBP
$4.41B
| $263K | ﹤0.01% |
+90,100
| New | +$240K |
|
3013
Ooma
OOMA
$601M
| $261K | ﹤0.01% |
+44,300
| New | +$283K |
|
|
SOFO
3014
DELISTED
Sonic Foundry, Inc. Common Stock
SOFO
| $261K | ﹤0.01% |
40,119
+1,700
| +4% | +$9.5K |
|
3015
Insight Enterprises
NSIT
$3.85B
| $258K | ﹤0.01% |
9,000
-11,500
| -56% | -$290K |
|
3016
Akebia Therapeutics
AKBA
$338M
| $257K | ﹤0.01% |
28,500
-80,700
| -74% | -$654K |
|
3017
Phio Pharmaceuticals
PHIO
$11.4M
| $257K | ﹤0.01% |
2
+1
| +100% | +$176K |
|
|
EGT
3018
DELISTED
Entertainment Gaming Asia Inc.
EGT
| $256K | ﹤0.01% |
128,191
+3,200
| +3% | +$6.13K |
|
3019
Perma-Fix Environmental Services
PESI
$337M
| $255K | ﹤0.01% |
68,844
+13,644
| +25% | +$51.2K |
|
3020
Huron Consulting
HURN
$2.76B
| $254K | ﹤0.01% |
+4,358
| New | +$241K |
|
3021
Protolabs
PRLB
$1.7B
| $254K | ﹤0.01% |
3,300
-2,600
| -44% | -$168K |
|
|
FFWM
3022
DELISTED
First Foundation Inc
FFWM
| $253K | ﹤0.01% |
22,600
-90,600
| -80% | -$997K |
|
|
EDN
3023
Edenor
EDN
$1.12B
| $252K | ﹤0.01% |
15,100
-31,800
| -68% | -$522K |
|
3024
Gorman-Rupp
GRC
$2.07B
| $252K | ﹤0.01% |
+9,700
| New | +$242K |
|
|
GSV
3025
DELISTED
Gold Standard Ventures Corp.
GSV
| $252K | ﹤0.01% |
+242,700
| New | +$198K |
|
Similar funds
Renaissance Technologies's Q1 2016 Portfolio in Review
As of Q1 2016, Renaissance Technologies held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Renaissance Technologies's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Renaissance Technologies added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Renaissance Technologies's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Renaissance Technologies fully exited Apple in Q1 2016, selling an estimated $470M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Renaissance Technologies opened 498 new positions and closed 403 in Q1 2016.
- Renaissance Technologies's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.